These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36909902)

  • 1. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients.
    Rymaszewska JE; Krajewski PK; Szczęch J; Szepietowski JC
    Postepy Dermatol Alergol; 2023 Feb; 40(1):35-39. PubMed ID: 36909902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfaction with Life and Coping Strategies among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
    Rymaszewska JE; Krajewski PK; Matusiak Ł; Maj J; Szepietowski JC
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
    Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
    JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
    Pavon Blanco A; Turner MA; Petrof G; Weinman J
    Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Expectations and Satisfaction with the Patient-Doctor Relationship in Hidradenitis Suppurativa.
    Rymaszewska JE; Karczewski M; Krajewski PK; Matusiak Ł; Maj J; Szepietowski JC
    Healthcare (Basel); 2023 Dec; 11(24):. PubMed ID: 38132029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015.
    Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
    Dermatology; 2024; 240(4):553-564. PubMed ID: 38621365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
    Hayama K; Fujita H; Hashimoto T; Terui T;
    J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4.
    van der Zee HH; van Huijstee JC; van Straalen KR; Jemec GBE; Zouboulis CC; Tzellos T; Prens EP
    Dermatology; 2024; 240(3):514-516. PubMed ID: 38118429
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Hidradenitis Suppurativa With Body Image.
    Schneider-Burrus S; Jost A; Peters EMJ; Witte-Haendel E; Sterry W; Sabat R
    JAMA Dermatol; 2018 Apr; 154(4):447-451. PubMed ID: 29466546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Depression, Quality of Life and Clinical Severity in Patients with Hidradenitis Suppurativa.
    Sampogna F; Fania L; Mastroeni S; Fusari R; Napolitano M; Ciccone D; Mazzanti C; Pallotta S; Panebianco A; Abeni D
    Acta Derm Venereol; 2020 Nov; 100(18):adv00319. PubMed ID: 32985674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychosocial burden of hidradenitis suppurativa in Singapore.
    Ooi XT; Choi E; Han H; Ahmad H; Patwardhan KR; Chandran NS
    JAAD Int; 2023 Mar; 10():89-94. PubMed ID: 36691658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.